Current advances in adenovirus nanocomplexes: more specificity and less immunogenicity

키워드

참고문헌 (49)

1. Heise, C., "An adenovirus E1A mutant that demonstrates potent and selective systemic anti-tumoral efficacy", Nat. Med., 6, pp.1134~1139 (2000)
2. Kim, J. H., "Relaxin expression from tumor-targeting adenoviruses and its intratumoral spread, apoptosis induction, and efficacy", J. Natl. Cancer Inst., 98, pp.1482~1493 (2006)
3. Chen, L., "Concomitant use of Ad5", 35 chimeric oncolytic adenovirus with TRAIL gene and taxol produces synergistic cytotoxicity in gastric cancer cells, 2009, pp.284, 141~148
4. Yoo, J. Y., "Short hairpin RNA-expressing oncolytic adenovirus-mediated inhibition of IL-8: effects on antiangiogenesis and tumor growth inhibition", Gene Ther., 15, pp.635~651 (2008)
5. Zhao, L., "The anti-tumor activity of TRAIL and IL-24 with replicating oncolytic adenovirus in colorectal cancer", Cancer Gene Ther., 13, pp.1011~1022 (2006)
6. Steinwaerder, D. S., "Tumor-specific gene expression in hepatic metastases by a replication-activated adenovirus vector", Nat. Med., 7, pp.240~243 (2001)
7. Chengalvala, M. V., "Adenovirus vectors for gene expression", Curr. Opin. Biotechnol., 2, pp.718~722 (1991)
8. Alemany, R., "Replicative adenoviruses for cancer therapy", Nat. Biotechnol., 18, pp.723~727 (2000)
9. Green, N. K., "Extended plasma circulation time and decreased toxicity of polymer-coated adenovirus", Gene Ther., 11, pp.1256~1263 (2004)
10. Choi, I. K., "Effect of decorin on overcoming the extracellular matrix barrier for oncolytic virotherapy", Gene Ther., 17, pp.190~201 (2010)
11. Gomes, E. M., "Antitumor activity of an oncolytic adenoviral-CD40 ligand (CD154) transgene construct in human breast cancer cells", Clin. Cancer Res., 15, pp.1317~1325 (2009)
12. Zhang, Y. A., "Antitumor activity of an oncolytic adenovirus-delivered oncogene small interfering RNA", Cancer Res., 66, pp.9736~9743 (2006)
13. Khuri, F. R., "A controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer", Nat. Med., 6, pp.879~885 (2000)
14. Nemunaitis, J., "Selective replication and oncolysis in p53 mutant tumors with ONYX-015, an E1B-55kD gene-deleted adenovirus, in patients with advanced head and neck cancer: a phase II trial", Cancer Res., 60, pp.6359~6366 (2000)
15. Kiang, A., "Multiple innate inflammatory responses induced after systemic adenovirus vector delivery depend on a functional complement system", Mol. Ther., 14, pp.588~598 (2006)
16. Singh, R., "Designer adenoviruses for nanomedicine and nanodiagnostics", Trends. Biotechnol., 27, pp.220~229 (2009)
17. Li, F., "Imaging viral behavior in Mammalian cells with self-assembled capsid-quantum-dot hybrid particles", Small, 5, pp.718~726 (2009)
18. Thompson, D. H., "Adenovirus in a synthetic membrane wrapper: an example of hybrid vigor?", ACS Nano, 2, pp.821~826 (2008)
19. Fisher, K. D., "HPMA copolymers for masking and retargeting of therapeutic viruses", Adv. Drug. Deliv. Rev., 62, pp.240~245 (2010)
20. Pearce, O. M., "Glycoviruses: chemical glycosylation retargets adenoviral gene transfer", Angew. Chem. Int. Ed. Engl., 44, pp.1057~1061 (2005)
21. Lee, G. K., "PEG conjugation moderately protects adenoassociated viral vectors against antibody neutralization", Biotechnol. Bioeng., 92, pp.24~34 (2005)
22. Jung, Y., "Retargeting of adenoviral gene delivery via Herceptin-PEG-adenovirus conjugates to breast cancer cells", J. Control Release, 123, pp.164~171 (2007)
23. Hofherr, S. E., "Modification of adenoviral vectors with polyethylene glycol modulates in vivo tissue tropism and gene expression", Mol. Ther., 16, pp.1276~1282 (2008)
24. Yao, X., "Systemic administration of a PEGylated adenovirus vector with a cancer-specific promoter is effective in a mouse model of metastasis", Gene Ther., 16, pp.1395~1404 (2009)
25. Chan, P., "Synthesis and characterization of chitosan-g-poly(ethylene glycol)-folate as a non-viral carrier for tumor-targeted gene delivery", Biomaterials, 28, pp.540~549 (2007)
26. Doronin, K., "Chemical modification with high molecular weight polyethylene glycol reduces transduction of hepatocytes and increases efficacy of intravenously delivered oncolytic adenovirus", Hum. Gene Ther., 20, pp.975~988 (2009)
27. Eto, Y., "PEGylated adenovirus vectors containing RGD peptides on the tip of PEG show high transduction efficiency and antibody evasion ability", J. Gene Med., 7, pp.604~612 (2005)
28. Gao, J. Q., "Effective tumor targeted gene transfer using PEGylated adenovirus vector via systemic administration", J. Control Release, 122, pp.102~110 (2007)
29. Gressner, A. M., "Preventive effects of acute inflammation on liver cell necrosis and inhibition of heparan sulphate synthesis in hepatocytes", J. Clin. Chem. Clin. Biochem., 24, pp.821~829 (1986)
30. Shayakhmetov, D. M., "Analysis of adenovirus sequestration in the liver, transduction of hepatic cells, and innate toxicity after injection of fiber-modified vectors", J. Virol., 78, pp.5368~5381 (2004)
31. Barton, K. N., "Polyethylene glycol (molecular weight 400 DA) vehicle improves gene expression of adenovirus mediated gene therapy", J. Urol., 175, pp.1921~1925 (2006)
32. Fisher, K. D., "Polymer-coated adenovirus permits efficient retargeting and evades neutralising antibodies", Gene Ther., 8, pp.341~348 (2001)
33. Green, N. K., "Retargeting polymer-coated adenovirus to the FGF receptor allows productive infection and mediates efficacy in a peritoneal model of human ovarian cancer", J. Gene Med., 10, pp.280~289 (2008)
34. Lanciotti, J., "Targeting adenoviral vectors using heterofunctional polyethylene glycol FGF2 conjugates", Mol. Ther., 8, pp.99~107 (2003)
35. Hofherr, S. E., "Polyethylene glycol modification of adenovirus reduces platelet activation, endothelial cell activation, and thrombocytopenia", Hum. Gene Ther., 18, pp.837~848 (2007)
36. Ogawara, K., "A nsovel strategy to modify adenovirus tropism and enhance transgene delivery to activated vascular endothelial cells in vitro and in vivo", Hum. Gene Ther., 15, pp.433~443 (2004)
37. Park, J. W., "Epidermal growth factor (EGF) receptor targeted delivery of PEGylated adenovirus", Biochem. Biophys. Res. Commun., 366, pp.769~774 (2008)
38. Bonsted, A., "Photochemically enhanced transduction of polymer-complexed adenovirus targeted to the epidermal growth factor receptor", J. Gene Med., 8, pp.286~297 (2006)
39. Morrison, J., "Virotherapy of ovarian cancer with polymer-cloaked adenovirus retargeted to the epidermal growth factor receptor", Mol. Ther., 16, pp.244~251 (2008)
40. Maeda, M., "Design and synthesis of a peptide-PEG transporter tool for carrying adenovirus vector into cells", Bioorg. Med. Chem. Lett., 15, pp.621~624 (2005)
41. Oh, I. K., "Folate immobilized and PEGylated adenovirus for retargeting to tumor cells", Bioconjug. Chem., 17, pp.721~727 (2006)
42. Park, Y., "Ionically crosslinked Ad", chitosan nanocomplexes processed by electro spinning for targeted cancer gene therapy, 2010, ~
43. Mok, H., "Enhanced intracellular delivery of quantum dot and adenovirus nanoparticles triggered by acidic pH via surface charge reversal", Bioconjug. Chem., 19, pp.797~801 (2008)
44. Park, J. W., "Physical adsorption of PEG grafted and blocked poly-L-lysine copolymers on adenovirus surface for enhanced gene transduction", J. Control Release, 142, pp.238~244 (2010)
45. Sarkar, D., "Eradication of therapy-resistant human prostate tumors using a cancer terminator virus", Cancer Res., 67, pp.5434~5442 (2007)
46. Sarkar, D., "Unique conditionally replication competent bipartite adenovirusescancer terminator viruses (CTV): efficacious reagents for cancer gene therapy", Cell Cycle., 5, pp.1531~1536 (2006)
47. Kim, P. H., "The effect of surface modification of adenovirus with an arginine-grafted bioreducible polymer on transduction efficiency and immunogenicity in cancer gene therapy", Biomaterials, 31, pp.1865~1874 (2010)
48. Cattaneo, R., "Reprogrammed viruses as cancer therapeutics: targeted, armed and shielded", Nat. Rev. Microbiol., 6, pp.529~540 (2008)
49. Saini, V., "An adenoviral platform for selective self-assembly and targeted delivery of nanoparticles", Small, 4, pp.262~269 (2008)

관련 논문AI추천